DrugDashboards

Lisdexamfetamine dimesylate

Lisdexamfetamine dimesylate capsules · LISDEXAMFETAMINE DIMESYLATE 70 mg/1 · Capsule · Oral · Solco Healthcare US,LLC

NDC 43547-0608-10 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 31% in a year, to $2.76 per unit — and generics that get this cheap tend to get abandoned rather than defended. It is in shortage right now — FDA lists the reason as “shortage of an active ingredient”. Put together: this is a fragile supply — if anything else goes wrong, there is very little slack to absorb it.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$2.76per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$6.94per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$2.76per CAPweighted avg manufacturer price $1.5669 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Sep 2023Sep 2026$2.76
37 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$82.78
#90 count
$248.34

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$11,862
64 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

63● High risk

Several kinds of pressure are visible at once — each line below is a condition that historically precedes supply trouble, and this market is stacking them.

  • 1 active manufacturer+30
  • in shortage now+25
  • price down 25% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for lisdexamfetamine dimesylate (oral solid) in the next 90 days

7 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA216266
TE code
AB
Approval date
Aug 25, 2023
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months
  • In shortage now — Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)Jul 14, 2023
    Shortage of an active ingredient
    month 38 — 3× the typical 14-month oral solid shortage · model puts 38% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lisdexamfetamine dimesylate capsules (Capsule)

LabelerStrengthFirst seenLast seen
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 10 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 20 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 30 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 40 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 50 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 60 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US,LLCLISDEXAMFETAMINE DIMESYLATE 70 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lisdexamfetamine dimesylate — NDC 43547-0608-10," retrieved September 3, 2026, https://drugdashboards.com/drug/43547060810.

Free to cite with attribution — see how the data is put together.